Navigation Links
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
Date:4/24/2013

eneral for patients in moderate-to-severe acute pain where intravenous access is not readily available."

This study randomized 101 patients following bunionectomy surgery in a 2:2:1 ratio to 30 mcg sufentanil, 20 mcg sufentanil or placebo treatment arms.  The intent-to-treat (ITT) population in this study averaged 42.5 years of age with an average Body Mass Index of 28.2, and was evenly balanced for males and females (51%:49%) and ethnicity (54% Caucasian:46% non-Caucasian).  Ninety-one percent of patients entering the study completed the full 12-hour study period.  SPID-12 scores were +6.53 for 30 mcg sufentanil-treated patients and -7.12 for placebo-treated patients, the difference between the two groups being highly statistically significant (p=0.003).  The 20 mcg sufentanil-treated patients did not achieve SPID-12 scores that differentiated from placebo.

"The results from this study, funded by the U.S. Army Medical Research and Materiel Command, provide further validation of our sufentanil NanoTab product platform as an effective treatment for moderate-to-severe acute pain," said Richard King , president and CEO of AcelRx. "AcelRx will present these positive top-line data to USAMRMC, and intends to hold an End of Phase 2 meeting with the FDA to define the Phase 3 clinical program for ARX-04."

About ARX-04

ARX-04 is a product candidate in development for the treatment of moderate-to-severe acute pain, consisting of sufentanil, a high therapeutic index opioid, in AcelRx's proprietary NanoTab technology that enables rapid sublingual absorption when the NanoTab is placed under the tongue.  As a result, sufentanil NanoTabs are designed to provide rapid onset of analgesia in a non-invasive method of administration and display a consistent pharmacokinetic profile due to a high percentage of drug being absorbed sublingually instead of through the gastrointestinal tract.  We believe
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
2. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
5. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
6. AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis
7. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
8. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
9. Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results
10. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Packaging Coordinators, Inc. ... definitive agreement to acquire Penn Pharmaceutical Services Limited (Penn ... in the United Kingdom ... Hope, Pennsylvania and Tokyo ... services, including Clinical and Commercial dosage form manufacturing, as ...
(Date:7/30/2014)... 30, 2014   Medical Equipment Solutions, Corp. ... a Department of Defense (US Army) contract valued at ... mobile MRI diagnostic machine and technical support staffing. As ... the Small Business Administration (SBA), Medical Equipment is proud ... the latest medical diagnostic equipment. The SBA 8-A certification ...
(Date:7/30/2014)... 2014 Die Apex Medical Corporation ... Bereich Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass ... Deutschland anfechten werden. Dieses hat entschieden, dass ... von ResMed verletze. Apex weist darauf hin, ... verschiedene Patente von ResMed Anfechtungen wegen Nichtigkeit ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3
(Date:7/30/2014)... McKinney, Texas (PRWEB) July 30, 2014 ... surgical hospital, is proud to announce the launch of ... throat (ENT), and general surgery. The doctors working in ... the needs of infants, children, and adolescents. Dr. Timothy ... Kapadia, Dr. Chad McDuffie, Dr. Neelesh Mehendale, and Dr. ...
(Date:7/30/2014)... Dialogic Inc. , the ... DollarPhone, the largest privately owned calling card platform ... ControlSwitch™ softswitch to offer enhanced session initiation ... to both its wholesale and prepaid customers. With ... to power DollarPhone’s network infrastructure, allowing the prepaid ...
(Date:7/30/2014)... A formal complaint has been ... the maker of the dialysis products GranuFlo and ... defrauded the state, its residents, physicians and dialysis ... they were recalled in 2012. There are hundreds ... pending in the U.S. District Court, District of ...
(Date:7/30/2014)... ,Middle-aged adults with a history of alcohol abuse are ... severe memory problems later in life, according to a ... could help doctors identify those at risk for memory ... "We already know there is an association between ... that understanding is based on asking older people how ...
(Date:7/30/2014)... 30, 2014 Sagacious Consultants, the premier ... $10,000 to a group of charities supporting veterans—Wounded Warrior ... Aaron Grider Foundation. This donation is part of Sagacious ... to contribute a donation every year to a charity ... their surrounding communities. , “We are thrilled to make ...
Breaking Medicine News(10 mins):Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 2Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 3Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 2Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 3Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2Health News:Sagacious Consultants Supports Veterans Charities With $10,000 Donation 2
... 6-7, Mandarin Oriental, Washington, D.C., ARLINGTON, ... industry,CEOs, along with top Wall Street analysts ... other government officials, will headline the,Generic Pharmaceutical ... 2007. The conference, "Generics: Prescription for Affordable,Health ...
... ATRC ), a medical device company focused on ... David J. Drachman, President and Chief Executive Officer, is,scheduled ... at the Four Seasons Hotel in Boston on Wednesday, ... cast and recording of the presentation will be available ...
... Italian study , , THURSDAY, Aug. 30 (HealthDay News) -- Stroke ... dying in the next year compared to those who stayed ... of other studies have shown the benefits of using statins ... the Italian study comes on the heels of a Spanish ...
... have no genetic blueprint to classify melanomas, a lethal form ... deeply the growth has invaded underlying skin tissue. The ... cancer, but some patients defy the odds and survive with ... patients with cancers of the same invasion depth and appearance ...
... reduce or prevent allergic reactions, group suggests , THURSDAY, ... people with seasonal allergies may suffer oral allergy syndrome ... pollen proteins from weeds, grass and trees and similar ... symptoms of OAS -- also known as pollen-food syndrome ...
... be behind ability to know the tone of a musical ... do-it-yourself study has found evidence for a possible genetic basis ... of a musical note without other notes as reference, researchers ... sibling of a person with absolute pitch also has absolute ...
Cached Medicine News:Health News:GPhA's 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts 2Health News:AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference 2Health News:Stopping Statins After Stroke Doubles Death Risk 2Health News:Stopping Statins After Stroke Doubles Death Risk 3Health News:Gene signature spells poor outcome 2Health News:Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome 2Health News:Is Perfect Pitch All in the Genes? 2
... The DNA Engine instrument is ... Unprecedented thermal uniformity and ... and block-to-block. This rugged ... cycler, it's a platform for new ...
... Start up kit. Includes configured Laptop PC ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
Medicine Products: